Cinclus Pharma at Aktiedagarna in Stockholm
Watch the presentation by Jesper Wiklund, Director of Corporate and Business Development at Cinclus Pharma, from Aktiedagarna in Stockholm September 17th (in Swedish).
Read more
In the spotlight
Check out the latest updates from Cinclus Pharma
Cinclus Pharma’s CEO Christer Ahlberg in interview with EFN Ekonomikanalen
Cinclus Pharma’s CEO Christer Ahlberg speaks in an interview with EFN Ekonomikanalen about the progress of the drug candidate linaprazan glurate, the strategic partnership with Zentiva, and the ongoing Phase III clinical trials (in Swedish).
Read more
A new paradigm shift driven by acid control
Highlights from the 2024 Annual Report: Market overview. 24-hour acid control is the most important characteristic to differentiate an acid-suppressive drug and to create optimal healing conditions.
Read more